Arcadia Biosciences

Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market. Its crop yield traits are utilized by its partners to develop higher yielding seeds for global crops, including wheat, rice, soybean, corn, and sugarcane, as well as for other crops, such as cotton, turf and trees. The Company's portfolio of agricultural productivity traits includes Nitrogen Use Efficiency (NUE), Water Use Efficiency (WUE), Drought Tolerance (DT), Salinity Tolerance (ST) and Herbicide Tolerance. It has presence in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada.
Company Growth (employees)
Type
Public
HQ
Davis, US
Size (employees)
57 (est)-28%
Arcadia Biosciences is headquartered in Davis, US

Key People at Arcadia Biosciences

Vic Knauf

Vic Knauf

Chief Scientific Officer
Zhongjin Lu

Zhongjin Lu

Vice President of Product Development
Don Emlay

Don Emlay

Vice President of Regulatory Affairs

Arcadia Biosciences Office Locations

Arcadia Biosciences has an office in Davis
Davis, US (HQ)
105 202 Cousteau Pl
Davis, US
202 Cousteau Place

Arcadia Biosciences Metrics

Arcadia Biosciences Financial Metrics

Revenue (2016)

$3.2 m

Revenue growth (2015-16), %

(41%)

Net income (2016)

($19.6 m)

Market capitalization (21-Mar-2017)

$35.6 m

Closing share price (21-Mar-2017)

$0.8

Cash (31-Dec-2016)

$2 m
Arcadia Biosciences's current market capitalization is $35.6 m.
Arcadia Biosciences's revenue was reported to be $3.2 m in FY, 2016 which is a 41.1% decrease from the previous period.
FY, 2015FY, 2016

Revenue

$5.4 m$3.2 m

Revenue growth, %

(41%)

R&D expense

$9 m$8.7 m

General and administrative expense

$11.1 m$12.3 m

Operating expense total

$21 m$21.8 m

EBIT

($15.6 m)($18.6 m)

EBIT margin, %

(287%)(584%)

Interest expense

($2.7 m)($1.3 m)

Pre tax profit

($19.6 m)

Income tax expense

($26 k)($25 k)

Net Income

($18 m)($19.6 m)
FY, 2015FY, 2016

Cash

$24 m$2 m

Inventories

$9.4 m

Current Assets

$52 m$52.2 m

PP&E

$585 k$508 k

Total Assets

$74.2 m$56.6 m

Total Debt

$49.9 m$50.3 m

Current Liabilities

$3.5 m$3.1 m

Additional Paid-in Capital

$172.2 m$173.7 m

Retained Earnings

($131.9 m)($151.6 m)

Total Equity

$40.2 m$22.2 m

Debt to Equity Ratio

1.2 x2.3 x

Debt to Assets Ratio

0.7 x0.9 x

Financial Leverage

1.8 x2.5 x
FY, 2015FY, 2016

Net Income

($18 m)($19.6 m)

Depreciation and Amortization

$294 k$304 k

Inventories

($305 k)

Accounts Payable

$6.9 m

Cash From Operating Activities

($15.1 m)($17.1 m)

Purchases of PP&E

($151 k)($231 k)

Cash From Investing Activities

($46.4 m)($5.3 m)

Cash From Financing Activities

$68.9 m$396 k

Interest Paid

$2.1 m$1 m

Income Taxes Paid

$149 k$29 k

Arcadia Biosciences Market Value History

Arcadia Biosciences Company Life

You may also be interested in